PRVIX (PRVIX) Stock Price & Analysis
PRVIX (PRVIX) rose 0.13% to USD 61.46 as of July 26, 2026 at 03:07 UTC, according to Nexqual real-time market data.
PRVIX last closed at USD 61.38; the session ranged USD 61.46–61.46 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 50.86–62.8 (NAS). Source: Nexqual, July 26, 2026 at 03:07 UTC.
Key Statistics (as of July 26, 2026 at 03:07 UTC)
| Price | USD 61.46 |
|---|---|
| Change | ▲ 0.13% (up) |
| Previous Close | USD 61.38 |
| Open | USD 61.46 |
| Day Range | USD 61.46 – 61.46 |
| 52-Week Range | USD 50.86 – 62.8 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRVIX)
Nexqual's technical model rates PRVIX "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 03:07 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.55 (neutral) |
| vs SMA50 | Above (USD 60.49) |
| MACD | 0.28 (positive) |
Financial Health Score (PRVIX)
Nexqual rates PRVIX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 03:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRMIX | T. Rowe Price Mid-Cap Value Fun | USD 38.54 | ▲ 0.47% |
| RPTIX | T. Rowe Price Mid-Cap Growth Fu | USD 98.95 | ▼ 0.52% |
| REIPX | T. Rowe Price Equity Income Fun | USD 44.69 | ▲ 0.25% |
| TRAIX | T. Rowe Price Capital Appreciat | USD 37.77 | ▼ 0.74% |
| THISX | T. Rowe Price Health Sciences F | USD 90.58 | ▲ 1.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 03:07 UTC. This page is informational and not investment advice.